SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-005050
Filing Date
2023-01-19
Accepted
2023-01-19 16:55:14
Documents
1
Period of Report
2023-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm233882-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm233882-2_4seq1.xml 4 6407
  Complete submission text file 0001104659-23-005050.txt   7783
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VOYAGER THERAPEUTICS, INC. 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Carter Todd Alfred (Reporting) CIK: 0001944011 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37625 | Film No.: 23537983